Recombinant Human HLA-C*07:02:01&B2M&RYR (RYRPGTVAL) Monomer Protein (HEK293)，Avi & His

The study of HLA-C*07:02:01, B2M, and RYR (RYRPGTVAL) monomer recombinant proteins is crucial for understanding immune responses and disease mechanisms. Human leukocyte antigen (HLA) molecules, especially Class I HLA-C, play a pivotal role in presenting peptides to CD8+ T cells, influencing the immune surveillance of infected or transformed cells. Variations in HLA alleles, like HLA-C*07:02:01, have been associated with different susceptibilities to various diseases, including infections and autoimmune disorders. The β2-microglobulin (B2M) protein is essential for the stability and surface expression of HLA Class I molecules. Therefore, studying the structural and functional aspects of these components aids in elucidating their roles in antigen presentation dynamics. The inclusion of RYR (RYRPGTVAL) as a peptide of interest adds another layer to this research, as specific peptides can modulate immune responses and potentially serve as targets for therapeutic interventions or vaccine design. By producing and characterizing the recombinant monomeric form of these proteins, researchers can investigate their interaction mechanisms, stability, and immunogenic properties, ultimately contributing to our understanding of how genetic variations affect immune responses. This research may not only shed light on fundamental immunological processes but also have implications in personalized medicine, where patient-specific HLA profiles can guide therapeutic strategies in infectious diseases and cancer treatment.